Infectious Disease Testing Products Market Segmented By Product(Test Kits, Consumables, Assays), By Type of Testing(POC(Point of Care), Laboratory), By End User (Hospitals, Diagnostic Centers, Research laboratories) By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030.
Infectious Disease Testing Products Market Overview
The Global Infectious Disease Testing Products Market size reached USD 27.8 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 46.4 billion by 2030. The global infectious disease testing products market is expected to exhibit a CAGR of 6.7% during the forecast period 2023-2030. The key market trend is the increasing demand for rapid and point-of-care testing.
For instance, in May 2023, Los Angeles-based startup Sensible Diagnostics says that it has developed a small, low-cost, sample-to-answer instrument that can perform PCR in 10 minutes. The firm expects to launch its system in early 2024 along with low-cost test cartridges, initially focusing on infectious disease testing at the point of care.
Infectious disease testing products are diagnostic tools and materials used to identify and detect the presence of infectious agents, such as bacteria, viruses, fungi and parasites, in patient samples. These products play a crucial role in diagnosing and managing infectious diseases by enabling healthcare professionals to accurately identify the causative agents and determine appropriate treatment options.
The infectious disease testing products market is driven by factors such as the increasing prevalence of infectious diseases, growing awareness & emphasis on early disease detection, technological advancements & innovations and expansion of Point-of-Care testing.
For instance, in March 2023, Biotia, a health tech company based in New York City, announced the launch of the GeoSeeq Watchtower System. Using genomics, the program provides support for 12 groups monitoring infectious disease hotspots to profile emerging infectious disease risks and early disease detection.
Infectious Disease Testing Products Market Scope
|
Metrics |
Details |
|
CAGR |
6.7% |
|
Size Available for Years |
2021-2030 |
|
Forecast Period |
2023-2030 |
|
Data Availability |
Value (US$) |
|
Segments Covered |
By Product, By Type of Testing, By End-User and By Region |
|
Regions Covered |
North America, Europe, Asia-Pacific, South America and Middle East & Africa |
|
Fastest Growing Region |
Asia-Pacific |
|
Largest Region |
North America |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights. |
To know more Insights - Download Sample
Infectious Disease Testing Products Market Dynamics
Increasing Prevalence of Infectious Diseases
The global burden of infectious diseases is a significant driver for the market. The prevalence of infectious diseases, including viral, bacterial and fungal infections, continues to rise. Factors such as population growth, urbanization, globalization and antimicrobial resistance contribute to the increasing incidence of infectious diseases, necessitating the need for accurate and efficient testing products.
For instance, in May 2023, WHO and its partners announced the launching of a global network to help protect people from infectious disease threats through the power of pathogen genomics. The International Pathogen Surveillance Network (IPSN) will provide a platform to connect countries and regions, improving systems for collecting and analyzing samples, using these data to drive public health decision-making and sharing that information more broadly.
High Cost of Testing Products
The cost of infectious disease testing products, particularly advanced molecular diagnostics and automated systems, can be substantial. The high costs associated with these products, including equipment, reagents and consumables, can limit their affordability, particularly in resource-limited settings. The affordability factor can act as a restraint, hindering widespread adoption and accessibility of these testing products.
High costs of testing products can trickle down to patients, particularly in settings where healthcare costs are borne by individuals. This can create financial burdens for patients, making it difficult for them to access necessary testing for infectious diseases.
Infectious Disease Testing Products Market Segment Analysis
The global infectious disease testing products market is segmented based on product, type of testing, end-user and region.
Based on the Type of Testing, Point-of-Care Testing Segment is Expected to Dominate the Market Share
The market for Point-of-Care testing holds 52.6% of the market share in 2022. POC testing products offer the advantage of providing quick results, often within minutes to hours. This rapid turnaround time enables healthcare professionals to make immediate treatment decisions and take appropriate actions, leading to improved patient outcomes.
Technological advancements have led to the development of portable POC testing devices and platforms. These compact and handheld devices enable healthcare professionals to perform testing at the patient's bedside or even in the field. The portability factor enhances the flexibility and accessibility of POC testing products.
Source: DataM Intelligence Analysis (2023)
Infectious Disease Testing Products Market Geographical Penetration
North America Holds the Largest Market Share Due to the Advanced Healthcare Infrastructure and Presence of Major Players
North America holds the largest market share during the forecast period due to the advanced healthcare infrastructure and the presence of major players. The region holds the 38.7% market share for the infectious disease testing products market in 2022. North America, has a well-developed healthcare infrastructure that includes a vast network of hospitals, clinics and diagnostic laboratories that supports the adoption and implementation of infectious disease testing products.
North America is home to several major market players in the infectious disease testing products industry. These companies have established strong distribution networks, brand recognition and a wide product portfolio, contributing to their market dominance.
Source: DataM Intelligence Analysis (2023)
Infectious Disease Testing Products Market Companies
The major global players include Co-Diagnostics Inc., Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Becton, Dickinson and Company (BD), Bio-Rad Laboratories, Thermo Fisher Scientific Inc, Ortho Clinical Diagnostics, Chembio Diagnostic Systems and Abacus Diagnostica.
COVID-19 Impact on Infectious Disease Testing Products Market
The COVID-19 pandemic created an unprecedented global demand for testing products to diagnose and monitor the infection. The need for widespread testing to identify infected individuals, trace contacts and implement appropriate control measures led to a substantial increase in the production and adoption of COVID-19 testing products.
The COVID-19 pandemic attracted new companies to enter the infectious disease testing market, including established players from other industries. Additionally, market consolidation occurred as larger companies acquired smaller diagnostic firms or formed partnerships to strengthen their COVID-19 testing portfolios.
Russia-Ukraine Conflict Analysis
The Russia-Ukraine war could lead to disruptions in global supply chains, including the production and distribution of infectious disease testing products. Ukraine is a significant producer of medical devices, including diagnostic products. Any disruption in the region's manufacturing capabilities, transportation infrastructure or export activities could lead to shortages or delays in the availability of testing products worldwide.
The Conflict situations may result in delays in regulatory processes and approvals, as government agencies and regulatory bodies focus on other urgent matters. This could impact the introduction of new testing products, as well as the timely review and clearance of existing products, leading to market uncertainty and slower innovation.
By Product
- Test Kits
- Consumables
- Assays
- Others
By Type of Testing
- Laboratory Testing
- Point-of-Care Testing
By End-User
- Hospitals
- Diagnostic Centers
- Research Laboratories
- Others
By Region
- North America
- The U.S.
- Canada
- Mexico
- Europe
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
- South America
- Brazil
- Argentina
- Rest of South America
- Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
- Middle East and Africa
Key Developments
- In May 2023, Appili Therapeutics Inc., a biopharmaceutical company focused on drug development for infectious diseases and biodefense, announced that the United States Patent and Trademark Office (USPTO) has published patent claims for ATI-1501 under the U.S. Application No. 18/072,154 and titled "Oral Formulations of Metronidazole and Methods of Treating an Infection Using Same".
- In April 2023, Biosynex SA, a French market leader specializing in the design and distribution of rapid tests, announced that it has completed its acquisition of Chembio Diagnostics, Inc., a leading point-of-care diagnostics company focused on infectious diseases.
Chembio is now part of Biosynex Group. The complementary nature of the technologies and product portfolio as well as the combination of market opportunities will be important growth drivers for the combined company.
Why Purchase the Report?
- To visualize the global infectious disease testing products market segmentation based on product, type of testing, end-user and region, as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development.
- Excel data sheet with numerous data points of infectious disease testing products market-level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as Excel consisting of key products of all the major players.
The Global Infectious Disease Testing Products Market Report Would Provide Approximately 54 Tables, 46 Figures and 195 Pages.
Target Audience 2023
- Manufacturers / Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
